Because we could not amplify EV-C104 by using primers specific for the viral protein (VP) 1 region (9), we used a reverse transcription PCR to amplify the 5′ -untranslated region/ VP4/VP2 gene (10). Amplicons of ≈600 bp were obtained for samples from 5 patients: 4 boys 2-11 months of age (BCH2859A, BCH2892A, BCH2894A, and BCH3034A) and a 30-year-old man (PUMCH12286). BLAST analysis (www.ncbi.nlm.nih. gov) of sequences of these amplicons showed that the 590-nt sequences had 94.0% identity with that of the EV-C104 prototype strain CL-12310945 The tree was generated with 1,000 bootstrap replicates. Neighbor-joining analysis of targeted nucleotide sequence was performed by using the Kimura 2-parameter model with the Molecular Evolutionary Genetics Analysis software version 4.0 (www. megasoftware.net/). Each strain detected in this study is indicated by a black circle and a specific identification code (BCH/PUMCH), followed by the patient number. Enterovirus 68, cocksackievirus (CV) A2, and echovirus (E) 3 (GenBank accession nos. AY426531, AY421760, and AY302553) were used as outgroups. PV, poliovirus. EV-C denotes the EV species to which EV-C104 belongs. Scale bar indicates evolutionary distance.
(EU840733). The amplicon contained 155 nt in the 5′-untranslated region, 207 nt in VP4, and 228 nt in VP2. Phylogenetic analysis of VP4/VP2 sequences showed that the 5 sequences obtained in this study (GenBank accession nos. JX560522-JX560526) belonged to genotype EV-C104 within the EV-C species (Figure) .
Virus Nucleotide identity of the EV-C104 sequences from this study was 99.5%-100% among BCH strains and 97.7%-98.0% between the PUMCH strain and the BCH strains. Deduced amino acid sequences in VP4/ VP2 among the BCH strains were identical, albeit for 1 aa difference for the PUMCH strain (BCH strains had Pro
110
, but the PUMCH strain had Leu
, which was consistent with strains detected in children and adults in Italy). Deduced amino acid sequences for all 5 strains isolated in this study had 97.9%-100.0% identity with those from Switzerland, Italy, and Japan. BCH strains were community acquired because these 4 patients came from different cities and were admitted to different wards on different dates.
The 4 EV-C104-positive boys all had fever and cough for >10 days before their hospitalization. Chest radiographs showed increased lung markings or patchy shadows diagnosed as pneumonia or bronchopneumonia. RSV or adenovirus was also detected in 3 of the boys. The fourth boy was positive for parainfluenza virus type 1, adenovirus, and bocavirus. Clinical outcomes for all 4 children were favorable. The EV-C104-positive man had fever, chills, pantalgia, and expectoration for 1 day before a URTI was diagnosed. EV-C104 was the only virus detected in this patient.
We compared relative viral loads for all viruses in the 5 patients and quantified viral load of EV-C104 and other viruses by using real-time PCR (methods available upon request). Median viral load in the 5 patients was 2.4 ×10
6 RNA copies/mL (range 5.6 × 10 4 -7.0 × 10 6 copies RNA/mL (Table, Appendix, wwwnc.cdc.gov/ EID/article/19/4/12-1435-T1.htm).
Overall, we found few (5/12,340) EV-C104-positive specimens. All EV-C104-positive children were coinfected with RSV or adenoviruses (high viral loads) in our study. The role of EV-C104 in RTIs needs to be further studied. Nevertheless, the finding of EV-C104-positive adults with high viral loads in China (3.9 ×10 6 RNA copies/mL) and Italy (2.0 × 10 6 RNA copies/mL) (7) indicates a possible association between EV-C104 with RTIs. Our data also confirm a wide distribution of EV-C104. (2) . The authors juxtapose this toll with minor injuries incurred by 10 soldiers who flouted explicit rules prohibiting contact with pet monkeys.
None of the bitten soldiers were reported to have sequelae. Furthermore, the first paragraph leaves the impression that a US Army soldier who died of rabies while serving in eastern Afghanistan may have contracted the disease from a macaque. This finding would be an extremely unlikely occurrence.
We have yet to see a single credible report of macaque-to-human transmission of rabies. In fact, we have yet to see a report of naturally acquired rabies infection in a macaque. Similarly, although antiviral prophylaxis is routinely prescribed to persons bitten by rhesus monkeys, there is not a single report of herpes B virus infection in a human outside the laboratory/zoo context, although thousands of persons are likely bitten by macaques in Asia every year (3, 4) .
In contrast, zoonotic transmission of simian foamy virus, a retrovirus ubiquitous in nonhuman primates, has been shown to occur from macaques to humans, probably through monkey bites, although this virus has not been shown to cause disease in humans (5) . Although it is advisable to avoid contact with monkeys, risk for disease transmission should be placed in proper perspective. Exaggerating risks of bites has, in the past, led to irrational culling of entire populations of macaques (6) .
